Clinical Biochemistry of MSK System Flashcards

1
Q

What are Biochemical markers of muscle damage?

A
  • Creatine Kinase (CK) - the most widely used, sensitive
  • Lactate Dehydrogenase (LDH), myoglobin, AST, Troponin, other enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some causes of increased CK based on Upper Limit of Normal ULN

A
  • >10 x Upper Limit of Normal (ULN): Often in polymyositis, rhabdomyolysis, Duchenne muscular dystrophy, myocardial infarction
  • 5-10 x ULN: Post-surgery, trauma, severe exercise, grand mal convulsion, myositis, carriers of Duchenne muscular dystrophy
  • < 5 x ULN: Physiological (related to muscle bulk e.g. weight lifters/athletes), hypothyroidism, drugs (e.g. statins – rare, 1 in 10,000)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Rhabdomyolysis?

  • causes (5)
A
  • Rapid destruction of striated muscle
  • Resulting in release of myoglobin and other muscle proteins and intracellular ions into the circulation

Causes

  • Severe exercise
  • Injury (trauma, electrocution, crush injuries, surgery)
  • Ischaemia
  • Metabolic (severe hypokalaemia or hypophosphataemia, malignant hyperpyrexia, McArdle disease, phosphofructokinase deficiency etc.)
  • Infections, toxins, drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the Metabolic causes of Rhabdomyolysis?

A
  • severe hypokalaemia
  • Hypophosphataemia
  • Malignant hyperpyrexia,
  • McArdle disease,
  • Phosphofructokinase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is seen in serology in Rhabdomyolysis cases? (7)

  • urine dip?
A
  • CK >10 x ULN
  • Hyperkalaemia
  • Hyperuricaemia (from purines, nephrotoxic)
  • Hyperphosphataemia
  • Hypocalcaemia
  • Rise in [creatinine]>[urea]
  • Metabolic acidosis (release of lactate and other acids)
  • urine dip is positive for peroxidase activity of myoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Renal failure in Rhabdomyolysis caused by?

A
  • Hypovolaemia
  • Metabolic acidosis (hypovol. release of organic acids)
  • Aciduria (causes myoglobin to convert to ferrihaemate, nephrotoxic, and precipitates causing physical obstruction)
  • Hyperuricaemia (purine → urate and intrarenal deposition)
  • Dehydration increases urine concn. and tubular obstruction by myoglobin casts, uric acid casts products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are the kidney’s protected in rhabdomyolysis?

A
  • Identify those at risk e.g. older age, higher CK
  • Fluid status/BP etc – proactive management of hypovolaemia
  • Less common:
    • Mannitol – osmotic diuretic
    • Urine alkalinisation – pHu >8 with bicarb infusion
    • Early haemofiltration
    • Note compartment syndrome is another complication of rhabdomyolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What biochemical investigations are done for muscle disease?

A
  • Routine biochemical studies
    • plasma sodium, potassium, chloride,
    • urea, bicarbonate, glucose, calcium, phosphate,
    • simple endocrine function tests
  • Plasma creatine kinase activity
  • Other enzymes (ALT, AST)
  • Highly specialised biochemical investigations (carnitine, fatty acids, etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What non-biochemical investigations can be done for muscle disease?

A
  • Histological Studies
  • Immunocytochemical studies
  • Genetic analyses
  • EMG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the three groups of Metabolic Muscle Disease?

A

1- Disorders of Carbohydrate Metabolism

2- Defects of Respiratory Chain (e.g. mitochondrial)

3- Defects of fatty acid oxidation (FAOD)

  • they are all to do with energy depletion or structural damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the symptoms of metabolic muscle disease?

A
  • Symptoms vary; most present early in life (infancy to adolescence) and can be mild (exercise intolerance) to fatal:
  • Exercise intolerance,
    • muscle pain (myalgia) after exercise, cramps,
    • muscle damage, myoglobinuria,
    • rhabdomyolysis (CK) leading to renal failure,
    • proximal muscle weakness,
    • hypotonia,
  • other organs may be affected e.g. heart, lungs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the key features and causes of Respiratory Chain (Mitochondrial Enzyme deficiencies/myopathies) metabolic muscle disease?

A

Key features

  • Multisystem disorders; very variable.
  • Muscle weakness, exercise intolerance,
  • MELAS: mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes
  • hearing loss, seizures, ataxia,
  • pigmentary retinopathy,
  • cardiomyopathy

Causes

  • Maternal inheritance
    • MERRF
    • Kearns SAYRE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the key features and causes of Carbohydrate metabolic muscle disease?

A

Key features

  • Chronic, progressive weakness with atrophy,
  • Cardiomegaly, hepatomegaly, macroglossia, respiratory dysfunction

Causes

  • Glycogen storage diseases (GSD): e.g.
    • McArdle disease (GSD V, myophosphorylase deficiency)
    • Pompe (GSD II, a-glucosidase deficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the key features of Defects of fatty acid oxidation metabolic muscle disease?

A

Key features

  • Muscle weakness and pain, myoglobinuria, exercise intolerance.
  • Symptoms usually present after a prolonged period of exercise.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What biochemical abnormalities would be seen in Metabolic muscle disease? (9)

A
  • Elevated CK (intermittent)
  • Elevated troponin
  • Hypoglycaemia
  • Abnormal LFTs (may be muscle damage)
  • Myoglobinuria
  • Increased plasma lactate
  • Increased cholesterol & triglycerides
  • Increased plasma urate
  • Abnormal acylcarnitines

- may only be present during an attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What Clinical investigations would you order in suspected Metabolic Muscle disease?

A
  • Family history, Neurological, Cardiac
  • *Gastrointestinal, Ophthalmology, Audiology (*mitochondrial)
    • CSF*
      • Lactate
  • Plasma
    • Lactate
    • Creatine kinase
    • Amino Acids
    • Acylcarnitines
    • Free carnitine
  • Urine
    • Amino acids
    • Organic acids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Give 3 Structural Muscle disease Disorders

A
  • Duchenne muscular dystrophy
  • Myaesthenia Gravis
  • Lambert-Eaton myaesthenic syndrome
18
Q

What is Duchenne Muscular Dystrophy?

  • presentation (physical and labs)
A
  • X-linked - dystrophin gene
  • Proximal weakness, Progressive
  • Gower’s sign, hypertrophy, contractures
  • Lab - very high CK, biopsy, genetic tests
19
Q

What is Myasthenia Gravis?

  • cause
A
  • Weakness, easy tiring
  • Especially cranial nerves
    • diplopia and ptosis
  • Due to antibodies AChR at the synapse
  • Occurs in young women OR a/w thymoma
20
Q

What is Lambert-Eaton myasthenic syndrome?

  • cause
A
  • Antibodies against the presynaptic voltage-gated calcium channels
  • Rare paraneoplastic
21
Q

How are DMARDs- methotrexate monitored?

  • why is monitoring important
A
  • PIIINP (type III procollagen peptide) is a marker of liver fibrosis and serial measurements can indicate need for a liver biopsy in those on long term methotrexate
22
Q

How are Immunosuppressant –azathioprine monitored?

  • why is monitoring important
A
  • TPMT (thiopurine methyl transferase) metabolises azathioprine to 6-methylxanthine (inactive)
  • Thiopurines are also metabolites of azathioprine that are myelotoxic. If levels low you use a lower dose.
23
Q

What are bone turnover markers?

A
  • A plethora, all have pitfalls including enzymes and crosslinks associated with collagen etc.
  • Serum CTX and urinary NTX: osteolysis
  • Serum bone ALP and PINP: osteogenesis
24
Q

What is CTX?

  • monitoring importance?
A
  • CTX (carboxy-terminal collagen crosslinks):
  • Specific and sensitive indicator of bone resorption, low if anti-resorptive agents e.g. bisphosphonate are working
25
Q

What is P1NP?

  • monitoring importance?
A
  • P1NP (procollagen type I terminal peptide):
  • Bone formation marker,
  • a fairly good marker of osteogenesis (higher being better).
26
Q

How is biochemistry involved in Osteoporosis diagnosis and management?

  • what other investigations are done?
A

Laboratory investigations

  • FBC, ESR, Creatinine, U & E, LFT ,s, Ca, P, TFT, PTH, 25(OH)D
  • Bone turnover markers (formation and resorption)
  • If secondary causes suspected
    • Gonadotrophins, testosterone, oestrogen
    • SPE, U-BJ/light chains etc, Coeliac screen, urine calcium, tryptase (systemic mastocytosis)
  • Radiology: DEXA, XR
27
Q

What are the broad categories of secondary causes of Osteoporosis?

A
  • Endocrine
  • Malignancy
  • Connective Tissue Disease
  • Drugs
  • Gastro-intestinal
28
Q

What are Gastrointestinal causes of Osteoporosis?

(4)

A
  • Gastrointestinal disease
  • Chronic liver disease – PBC
  • Chronic Renal Failure
  • Post Organ Transplant
29
Q

What Drugs cause Osteoporosis?

(4)

A
  • Glucocorticoids
  • Alcohol
  • Heparin
  • Anticonvulsants
30
Q

What Connective Tissues diseases cause Osteoporosis?

(4)

A
  • Osteogenesis imperfecta
  • Marfan’s syndrome
  • Ehlers Danlos syndrome
  • Homocystinuria
31
Q

What are Malignancy causes of Osteoporosis?

(4)

A
  • Myeloma
  • Mastocytosis
  • Lymphoma
  • Leukaemia
32
Q

What are Endocrine causes of Osteoporosis?

(4)

A
  • 1° and 2° Hypogonadism
  • Thyrotoxicosis
  • Hyperparathyroidism
  • Cushing’s Syndrome
33
Q

What is the clinical significance of Urate?

  • what is it/ how does it behave
  • pathologies?
A
  • Urate is a by-product of purine metabolism but can precipitate out in soft tissues, kidneys (renal stones) and joints (gout inflammation caused by monosodium urate crystals)
  • Solubility decreased by low pH, and lower temperatures and affected by the concentration of other ions
  • Also some IMD (inherited metabolic diseases) of purine metabolism
34
Q

How is Uric Acid generated?

  • important enzymes in treatment?
A
  • Xanthine oxidase converts Hypoxanthine to Xanthine which forms uric acid
    • this can be inhibited by Allopurinol and Febuxostat
35
Q

What is the clinical presentation of Osteomalacia?

  • causes (4)
A
  • Malaise, Bone pain, Proximal muscle weakness/myopathy
  • Alk phosphatase raised, [Ca2+] low/N, [PO42-] low/N
  • Looser zones in X-rays
36
Q

What is the biochemical presentation of the following causes of Osteomalacia?

  • Vit D Deficiency
  • Low 1,25 D (renal failure, Vit D dependent Rickets type I = mutated 1alpha hydroxylase)
  • Vit D dependent Rickets Type II (mutation in VDR)
  • Low phosphate
A
37
Q

What are other differentials for Osteomalacia?

A
  • Other metabolic bone disease: Osteoporosis / PTH bone disease / Neoplastic
  • Proximal muscle weakness: PMR, Muscular dystrophy
  • Bone pain: Paget’s, Rheumatological, Leukaemia, Myeloma
  • Unexplained fractures: Osteoporosis, Paget’s disease
  • Psychological illness
38
Q

What is Paget’s Disease?

A
  • Focal disorder of bone remodelling, unknown cause
  • Characterised by
    • Accelerated bone turnover
    • Initiated by increased osteoclast mediated resorption
  • Abnormal bone remodelling – weakened, disorganised, enlarged
  • Monostotic / polyostotic: pelvis, femur, tibia, skull, spine
  • Malignant complications: Sarcoma <1%
39
Q

What are the Features of Paget’s Disease?

A
  • Bone pain
  • Bone enlargement / deformity
  • Degenerative joint disease
  • Fractures
  • Auditory complications
  • Neurological complications
  • Immobilisation hypercalcaemia
  • High output cardiac failure (multifactorial)
40
Q

What is the relation between Hypothyroidism and Muscle pathologies?

A
  • Muscle conditions/symptoms with hypothyroidism are common (30-80%) – usually myalgia, weakness, cramps, fatigability and stiffness.
  • Get delay in tendon reflexes, proximal muscle weakness and rarely hypertrophy (legs, tongue).
  • CK 10-100*normal, no correlation to weakness. Rhabdomyolysis is rare.
  • Replacing thyroid hormones should reverse the condition
    • so if they present with hypercholesterolaemia always rule out hyperthyroidism as treating that would reverse the effects
  • rare syndromic presentation
    • Kocher-Debré-Sémélaigne syndrome; called Herculean appearance in children